Wynnefield Capital »

Recro Pharma shares owned by Wynnefield Capital

Quarter-by-quarter ownership of Recro Pharma (SCTL) shares owned by Wynnefield Capital from 13F filings

Historical chart of Wynnefield Capital investment in Recro Pharma

Tip: Access up to 7 years of quarterly data

All positions including Recro Pharma held by Wynnefield Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recro Pharma by Wynnefield Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6k 13k 0.35
2023-09-30 $6.1k 13k 0.47
2023-06-30 $14k 13k 1.10
2023-03-31 $16k 13k 1.19
2022-12-31 $19k 13k 1.49
2022-09-30 $21k 13k 1.62
2022-06-30 $10k 13k 0.77
2022-03-31 $23k 13k 1.77
2021-12-31 $22k 13k 1.69
2021-09-30 $27k 13k 2.08
2021-06-30 $29k 13k 2.23
2021-03-31 $36k 13k 2.77
2020-12-31 $37k 13k 2.85
2020-09-30 $27k 13k 2.08
2020-06-30 $59k 13k 4.54
2020-03-31 $106k 13k 8.15